Federal contract award
75N94023F00001
75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | 75N94020D00004 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $113.4K |
| Current contract value | $113.4K |
| Potential contract value / ceiling | $113.4K |
| Start date | Sep 28, 2023 |
| Current end date | Feb 28, 2026 |
| Potential end date | Feb 28, 2026 |
| Latest award activity | Apr 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 21, 2026 | P00004 | $-12.7K | NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL PHASE 1: NON-SEVERABLE |
| Nov 26, 2025 | P00003 | $0 | NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE FY22 CAN 8054183 |
| Mar 13, 2025 | P00002 | $0 | NICHD: R&D: OVAPRENE VAGINAL DEVICE CLINICAL TRIAL: NON-SEVERABLE FY22 CAN 8054183 |
| Sep 24, 2024 | P00001 | $0 | 75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183 |
| Sep 25, 2023 | 0 | $126.1K | 75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.